Efficacy and safety of PEG-rhG-CSF in primary and secondary prevention of chemotherapy-induced neutropenia.

被引：0
|
作者：
Zhu, Jun
Li, Huiping
Fan, Zhengfu
Gao, Yunong
Tu, Meifeng
Shao, Bin
Gao, Tian
机构：
[1] Peking Univ, Canc Hosp & Inst, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China
[2] Peking Univ, Canc Hosp, Beijing, Peoples R China
[3] Beijing Canc Hosp, Beijing, Peoples R China
[4] Peking Univ, Canc Hosp & Inst, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19051
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effect of PEG-rhG-CSF on primary prevention of neutropenia after simultaneous radiotherapy and chemotherapy
    Ma, Hongfang
    Zhu, Xiaoli
    Gao, Lingna
    Zhong, Xiaoyu
    Zhong, Baogui
    MINERVA SURGERY, 2023, 78 (03): : 309 - 310
  • [2] Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients
    Yantao Jiang
    Ju Zhang
    Jianxin Zhong
    Hao Liao
    Jiayang Zhang
    Yaxin Liu
    Yuehua Liang
    Huiping Li
    BMC Cancer, 23
  • [3] Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients
    Jiang, Yantao
    Zhang, Ju
    Zhong, Jianxin
    Liao, Hao
    Zhang, Jiayang
    Liu, Yaxin
    Liang, Yuehua
    Li, Huiping
    BMC CANCER, 2023, 23 (01)
  • [4] Study of PEG-rhG-CSF for the prevention of neutropenia in concurrent chemoradiotherapy for nasopharyngeal carcinoma
    Yang, Lu
    Yu, Lei
    Du, Xue
    Cui, Yu
    Du, Guobo
    PLOS ONE, 2025, 20 (01):
  • [5] Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer
    Li, Weiwei
    Dong, Mohan
    Huang, Shigao
    Shi, Liu
    Yang, Hua
    Zhang, Ying
    Gong, Jie
    Shi, Mei
    Wei, Lichun
    Zhao, Lina
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (02): : 310 - 316
  • [6] Efficacy and safety of same-day versus next-day administration of PEG-rhG-CSF for the prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia in patients with breast cancer: a retrospective cohort study
    Zhang, Yu-Fei
    Zhang, Rou-Mei
    Gu, Wen-Xin
    Jin, Yi-Ting
    Ma, Chun-Lai
    CURRENT MEDICAL RESEARCH AND OPINION, 2024,
  • [7] The efficacy and safety of the prophylactic application of PEG-rhG-CSF in radiotherapy with weekly concurrent chemotherapy for cervical cancer
    Chen, Huimin
    Ma, Yiming
    Wang, Dandan
    Wu, Hao
    Zhang, Mingchuan
    Xu, Yuanyuan
    Cheng, Shuxia
    BMC CANCER, 2024, 24 (01)
  • [8] A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF PEG-G-CSF IN CANCER PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA.
    Li, Z.
    Jin, W.
    Mei, H.
    Qi, W.
    Hua, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S40 - S40
  • [9] A prospective, randomized, controlled clinical trial comparing different PEG-rhG-CSF administration times to treat chemotherapy-induced neutropenia and febrile neutropenia in early breast cancer
    Zha, Xiaoming
    Wang, Jue
    Xu, Yinggang
    He, Jinzhi
    Wang, Ye
    Zhang, Weiwei
    Wan, Xinyu
    Shi, Wenjie
    CANCER RESEARCH, 2024, 84 (09)
  • [10] A Randomized Controlled Clinical Study of Peg-Rhg-CSF for Preventing Chemotherapy-Induced Neutropenia in Patients with B-Cell Non-Hodgkin Lymphoma
    Zhen, Changqing
    Ding, Mei
    Lu, Kang
    Ge, Xueling
    Chen, Na
    Fang, Xiaosheng
    Sui, Xiaohui
    Jiang Yujie
    Liu, Xin
    Li, Ying
    Wang, Xianghua
    Li, Ying
    Zhang, Lingyan
    Xu, Hongzhi
    Fan, Juan
    Wang, Xin
    BLOOD, 2019, 134
12345